327.99 0.00 (0.00%)
After hours: 6:18PM EDT
|Bid||0.00 x 800|
|Ask||328.90 x 800|
|Day's Range||319.92 - 328.46|
|52 Week Range||186.09 - 335.99|
|PE Ratio (TTM)||48.61|
|Earnings Date||Jul 23, 2018 - Jul 27, 2018|
|Forward Dividend & Yield||1.12 (0.37%)|
|1y Target Est||305.50|
NEW YORK , June 8, 2018 /PRNewswire/ -- S&P Dow Jones Indices will make the following index adjustments to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 to ensure each index more appropriately represents ...
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Services sector is rising.
VITAS Healthcare, the nation’s leading provider of end-of-life care, has opened a new, free-standing Inpatient Hospice Unit (IPU) at St. Joseph’s Wayne Hospital, caring for patients from Passaic, Bergen, Morris and Essex counties. VITAS currently operates 28 IPUs nationwide and this is the first, free-standing hospice IPU in northern New Jersey. The VITAS IPU is located at 220 Hamburg Turnpike, Wayne, NJ 07470.
Chemed Corporation (CHE) today announced that it will deliver a presentation at the Jefferies 2018 Global Healthcare Conference on Tuesday, June 5, 2018, at approximately 10:30 a.m. (ET) in New York City. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days.
NEW YORK, May 22, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of El ...
Shareholders of Chemed Corporation (CHE) today elected a slate of 10 directors at the Company’s 2018 annual shareholders’ meeting. Shareholders ratified the continuation of PricewaterhouseCoopers LLP as the Company’s independent accountants for 2018. Shareholders also approved Chemed’s executive compensation and the 2018 Stock Incentive Plan.
Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Despite the bottom line of Orthofix (OFIX) betters estimates, the company's shares drop due to trimmed 2018 earnings outlook.
BioScrip's (BIOS) shift in strategy to raise core revenue mix hampers growth in Q1. Year-over-year rise in core product mix buoys optimism.
Favorable underlying market trends along with a slew of new product and service offerings by STERIS (STE) instill confidence in investors.